London-based deal experts are the advisors for this collaboration and the ongoing partnering efforts for IntoCell's platform technologies and its lead programme, B7-H3 ADC. LONDON, Jan.
PharmaVentures advises Lausanne Hospital (CHUV) and EPFL on their collaboration and founding of Aerium Therapeutics to develop their highly potent SARS-CoV-2 antibodies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LONDON, March 24, 2022 /PRNewswire/ PharmaVentures is pleased to announce that it acted as transaction advisor to Lausanne University Hospital (CHUV) and EPFL in Switzerland on their commercial
/PRNewswire/ PharmaVentures today announced it has moved its operational headquarters from Oxford to London as part of its continued strategic expansion..
LONDON, Feb. 10, 2022 /PRNewswire/ PharmaVentures today announced it has moved its operational headquarters from Oxford to London as part of its continued strategic expansion. The company